MFBTD
NBRV

MB Financial Bank - Trust Department’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

MB Financial Bank - Trust Department’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4
Closed -$3K – 428
2018
Q3 		$3K Buy
+4
New +$2.83K ﹤0.01% 416

Other funds holding NBRV

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MB Financial Bank - Trust Department's NBRV Position: Q4 2018 in Review

MB Financial Bank - Trust Department sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2018, closing a stake of 4 shares — an estimated $3K sold.

MB Financial Bank - Trust Department first reported a position in NBRV in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 47 funds tracked by Wall St. Rank hold NBRV as of Q4 2018.

  • MB Financial Bank - Trust Department reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2018 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 4 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2018, an estimated $3K.
  • MB Financial Bank - Trust Department first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2018 and held it in 1 quarter.
  • MB Financial Bank - Trust Department's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $3K in Q3 2018.
  • 47 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2018.

Based on MB Financial Bank - Trust Department's 13F filing for Q4 2018, filed 9 Jan 2019.